Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis

被引:36
|
作者
Boltzen, U. [1 ,2 ]
Eisenreich, A. [1 ]
Antoniak, S. [3 ]
Weithaeuser, A. [1 ,2 ]
Fechner, H. [1 ]
Poller, W. [1 ]
Schultheiss, H. P. [1 ]
Mackman, N. [3 ]
Rauch, U. [1 ]
机构
[1] Charite, Zentrum Herz & Kreislaufmed, D-12200 Berlin, Germany
[2] Free Univ Berlin, Inst Biochem, D-14195 Berlin, Germany
[3] Univ N Carolina, Dept Med, UNC McAllister Heart Inst, Div Hematol & Oncol, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
Apoptosis; Cardiomyocytes; Tissue Factor; Inflammation; Signaling; NF-KAPPA-B; FACTOR EXPRESSION; PROMOTES SURVIVAL; GENE-TRANSFER; ACTIVATION; CELLS; AKT; PATHWAY; INJURY; BCL-2;
D O I
10.1016/j.yjmcc.2012.01.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue Factor (IF) is expressed in various cell types of the heart, such as cardiomyocytes. In addition to its role in the initiation of blood coagulation, the TF:FVIIa complex protects cells from apoptosis. There are two isoforms of Tissue Factor (IF): "full length" (fl)TF an integral membrane protein, and alternatively spliced (as) TF-a protein that lacks a transmembrane domain and can thus be secreted in a soluble form. Whether asTF or flTF affects apoptosis of cardiomyocytes is unknown. In this study, we examined whether asTF or flTF protects murine cardiomyocytes from TNF-alpha-induced apoptosis. We used murine cardiomyocytic HL-1 cells and primary murine embryonic cardiomyocytes that overexpressed either murine asTF or murine flTF, and stimulated them with TNF-alpha to initiate cell death. Apoptosis was assessed by annexin-V assay, propidium iodide assay, as well as activation of caspase-3 and -9. In addition, signaling via integrins, Akt, NF kappa B and Erk1/2, and gene-expression of Bcl-2 family members were analyzed. We here report that overexpression of asTF reduced phosphatidylserine exposure upon TNF-alpha-stimulation. asTF overexpression led to an increased expression and phosphorylation of Akt, as well as up-regulation of the anti-apoptotic protein Bcl-x(L). The anti-apoptotic effects of asTF overexpression were mediated via alpha(v)beta(3)/Akt/NF kappa B signaling and were dependent on Bcl-x(L) expression in HL-1 cells. The anti-apoptotic activity of asTF was also observed using primary cardiomyocytes. Analogous yet less pronounced anti-apoptotic sequelae were observed due to overexpression of flTF. Importantly, cardiomyocytes deficient in IF exhibited increased apoptosis compared to wild type cells. We propose that asTF and flTF protect cardiomyocytes against TNF-alpha-induced apoptosis via activation of specific signaling pathways, and up-regulation of anti-apoptotic members of the Bcl-2 protein family. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1056 / 1065
页数:10
相关论文
共 50 条
  • [1] Angiogenic effect of alternatively spliced and full-length tissue factor inhibition by TFPI
    Giannarelli, C.
    Turu, M. M.
    Cimmino, G.
    Fuster, V
    Badimon, J. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 606 - 606
  • [2] Differential localization of full length tissue factor and alternatively spliced tissue factor in breast cancer cells
    Kocaturk, B.
    van den Berg, Y. W.
    Reitsma, P. H.
    Bogdanov, V. Y.
    Versteeg, H. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 890 - 890
  • [3] Expression of alternatively-spliced human tissue factor, but not full-length tissue factor, enhances tumor growth and tumor-associated vasculature.
    Soff, Gerald A.
    Hobbs, Jennifer
    Hyman, Emily
    Cundiff, Deborah L.
    BLOOD, 2006, 108 (11) : 495A - 495A
  • [4] Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells
    Unlu, B.
    Bogdanov, V. Y.
    Versteeg, H. H.
    THROMBOSIS RESEARCH, 2017, 156 : 1 - 7
  • [5] Alternatively Spliced Tissue Factor Exerts Greater Angiogenic Potency than Full-Length Tissue Factor via HIF-1a Induction in Complicated Atherosclerotic Plaques
    Giannarelli, Chiara
    Alique, Matilde
    Rodriguez, David T.
    Calcagno, Claudia
    Hutter, Randolph
    Millnn, Antoine
    Faries, Peter
    Fayad, Zahi A.
    Soff, Gerald
    Hajjar, Roger J.
    Fusters, Valentin
    Badimon, Juan J.
    CIRCULATION, 2013, 128 (22)
  • [6] Alternatively spliced and full-length tissue factor reveal a non-identical relationship to clinicopathological parameters in a large cohort of human breast cancer
    Van den Berg, Y. W.
    Mieog, D. J. S.
    De Kruijf, E. M.
    Wang, J.
    Sajet, A.
    Kuppen, P. J. K.
    Van de Velde, C. J. H.
    Reitsma, P. H.
    Osanto, S.
    Bogdanov, V. Y.
    Versteeg, H. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 803 - 803
  • [7] Identification and characterization of murine alternatively spliced tissue factor
    Bogdanov, VY
    Kirk, RI
    Miller, C
    Hathcock, JJ
    Vele, S
    Gazdoiu, M
    Nemerson, Y
    Taubman, MB
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) : 158 - 167
  • [8] Alternatively spliced isoforms of tissue factor pathway inhibitor
    Maroney, Susan A.
    Ellery, Paul E.
    Mast, Alan E.
    THROMBOSIS RESEARCH, 2010, 125 : S52 - S56
  • [9] Alternatively Spliced Tissue Factor Is Not Sufficient for Embryonic Development
    Sluka, Susanna H. M.
    Akhmedov, Alexander
    Vogel, Johannes
    Unruh, Dusten
    Bogdanov, Vladimir Y.
    Camici, Giovanni G.
    Luescher, Thomas F.
    Ruf, Wolfram
    Tanner, Felix C.
    PLOS ONE, 2014, 9 (05):
  • [10] Alternatively spliced tissue factor: a physiological or pathological phenomenon?
    Versteeg, H. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 500 - 500